{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:45:45Z","timestamp":1648835145916},"reference-count":11,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3892\/mco.2016.861","type":"journal-article","created":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T07:25:14Z","timestamp":1461137114000},"page":"207-209","source":"Crossref","is-referenced-by-count":4,"title":["Esophageal metastasis secondary to extranodal nasal-type natural killer\/T-cell lymphoma: A case report"],"prefix":"10.3892","volume":"5","author":[{"given":"ZHENG-YING","family":"MO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HONG-WEI","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEN-BIN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QING-LE","family":"LIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,4,20]]},"reference":[{"key":"key20180107150441_b1-mco-0-0-861","first-page":"285","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2008","journal-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"key20180107150441_b2-mco-0-0-861","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"International Peripheral T-Cell Lymphoma Project: Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: A study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"key20180107150441_b3-mco-0-0-861","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.pai.0000205062.27174.56","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: Study of clinicopathologic and prognosis factors in a series of 78 cases from Peru","volume":"15","author":"Barrionuevo","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20180107150441_b4-mco-0-0-861","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hon.847","article-title":"Extranodal NK\/T-cell lymphoma: diagnosis and treatment cues","volume":"26","author":"Suzuki","year":"2008","journal-title":"Hematol Oncol"},{"key":"key20180107150441_b5-mco-0-0-861","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-9966-33-7","article-title":"The downregulation of PRDM1\/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK\/T-cell lymphoma, nasal type","volume":"33","author":"Liang","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107150441_b6-mco-0-0-861","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1182\/blood.V85.10.2654.bloodjournal85102654","article-title":"Development of human T and natural killer cells","volume":"85","author":"Spits","year":"1995","journal-title":"Blood"},{"key":"key20180107150441_b7-mco-0-0-861","first-page":"276","article-title":"Aggressive NK-cell leukaemia","author":"Chan","year":"2008","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"key20180107150441_b8-mco-0-0-861","first-page":"204","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2001","journal-title":"World Health Organization Classification of Tumors"},{"key":"key20180107150441_b9-mco-0-0-861","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-cell lymphomas and leukemias: A spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"key20180107150441_b10-mco-0-0-861","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Au","year":"2004","journal-title":"Blood"},{"key":"key20180107150441_b11-mco-0-0-861","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","article-title":"Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2016.861\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T22:07:50Z","timestamp":1600466870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2016.861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,20]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,20]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.3892\/mco.2016.861"],"URL":"https:\/\/doi.org\/10.3892\/mco.2016.861","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,20]]}}}